STROKE PREVENTION

The efficacy of clopidogrel plus aspirin vs aspirin alone were consistent between patients with and without intracranial arterial stenosis (ICAS), in the Clopidogrel in High Risk Patients with Acute Nondisabling Cerebrovascular Events (CHANCE) trial.

Results indicated higher rate of recurrent stroke in minor stroke or high risk TIA patients with ICAS than in those without.

There was no significant difference in the response to the 2 antiplatelet therapies between patients with and without ICAS in the CHANCE trial.

Dual antiplatelet therapy in stroke and ICAS
Neurology
09/09/2015
Liu L, et al.

Responder

Introduce tus datos o haz clic en un icono para iniciar sesión:

Logo de WordPress.com

Estás comentando usando tu cuenta de WordPress.com. Cerrar sesión / Cambiar )

Imagen de Twitter

Estás comentando usando tu cuenta de Twitter. Cerrar sesión / Cambiar )

Foto de Facebook

Estás comentando usando tu cuenta de Facebook. Cerrar sesión / Cambiar )

Google+ photo

Estás comentando usando tu cuenta de Google+. Cerrar sesión / Cambiar )

Conectando a %s